Clinical trial
Topical Amitriptyline and Ketamine Cream in Treating Peripheral Neuropathy…
NCT00471445 · Gary Morrow, Other · Completed
Key facts
| NCT number | NCT00471445 |
|---|---|
| Title | Topical Amitriptyline and Ketamine Cream in Treating Peripheral Neuropathy Caused by Chemotherapy in Cancer Patients |
| Official title | Assessment of Topical Treatment Response With Amitriptyline and Ketamine: Combination Trial in Chemotherapy Peripheral Neuropathy (ATTRACT-CPN) |
| Lead sponsor | Gary Morrow, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Neurotoxicity, Pain, Peripheral Neuropathy, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug, Other |
| Interventions | ketamine/amitriptyline NP-H cream, placebo |
| Enrollment | 462 |
| Start date | Oct 1, 2007 |
| Primary completion | Sep 1, 2013 |
| Completion | Nov 1, 2013 |
| First posted | May 10, 2007 |
| Last update posted | Nov 9, 2015 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: